Rhythmic delta activity represents a form of nonconvulsive status epilepticus in anti-NMDA receptor antibody encephalitis

Epilepsy and Behavior

Volumn 20, Issue 2, 2011, Pages 392-394

  Kirkpatrick, McNeill P ^a   Clarke, Charles D ^a   Sonmezturk, Hasan H ^a   Abou Khalil, Bassel ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anti NMDA receptor antibodies; Coma; Felbamate; Limbic encephalitis; Psychosis; Status epilepticus

Indexed keywords

DIAZEPAM; ETIRACETAM; FELBAMATE; LORAZEPAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OXCARBAZEPINE; PENTOBARBITAL; PHENYTOIN; PREDNISONE; RITUXIMAB; VALPROIC ACID;

ADULT; AMNESIA; ARTICLE; BRAIN DISEASE; CANCER SURGERY; CASE REPORT; COMA; DELTA RHYTHM; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCORTICOGRAPHY; ELECTROENCEPHALOGRAM; ENCEPHALITIS; EPILEPSY; EPILEPTIC STATE; FEMALE; HUMAN; LUMBAR PUNCTURE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY ENCEPHALITIS; NONCONVULSIVE EPILEPTIC STATE; NUCLEAR MAGNETIC RESONANCE IMAGING; PENTOBARBITAL INDUCED COMA; PLASMAPHERESIS; TERATOMA;

ANTIBODIES, ANTI-IDIOTYPIC; DELTA RHYTHM; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS; FEMALE; HUMANS; RECEPTORS, N-METHYL-D-ASPARTATE; STATUS EPILEPTICUS; YOUNG ADULT;

EID: 79951673027     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2010.11.020     Document Type: Article

References (13)

1. Dalmau J., Tuzun E., Wu H.Y., et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007, 61:25-36.
2. Dalmau J., Gleichman A.J., Hughes E.G., et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008, 7:1091-1098.
3. Johnson N., Henry C., Fessler A.J., Dalmau J. Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus. Neurology 2010, 75:1480-1482.
4. Bayreuther C., Bourg V., Dellamonica J., Borg M., Bernardin G., Thomas P. Complex partial status epilepticus revealing anti-NMDA receptor encephalitis. Epileptic Disord 2009, 11:261-265.
5. Lousa M., Sanchez-Alonso S., Rodriguez-Diaz R., Dalmau J. Status epilepticus with neuron-reactive serum antibodies: response to plasma exchange. Neurology 2000, 54:2163-2165.
6. Kaplan P.W. EEG criteria for nonconvulsive status epilepticus. Epilepsia 2007, 48(Suppl. 8):39-41.
7. Hirsch L.J., Brenner R.P., Drislane F.W., et al. The ACNS subcommittee on research terminology for continuous EEG monitoring: proposed standardized terminology for rhythmic and periodic EEG patterns encountered in critically ill patients. J Clin Neurophysiol 2005, 22:128-135.
8. Young G.B., Jordan K.G., Doig G.S. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology 1996, 47:83-89.
9. Coyle J.T. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 2006, 26:365-384.
10. Waxman E.A., Lynch D.R. N-Methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist 2005, 11:37-49.
11. Zandi M.S., Irani S.R., Follows G., Moody A.M., Molyneux P., Vincent A. Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma. Neurology 2009, 73:2039-2040.
12. Chang H.R., Kuo C.C. Molecular determinants of the anticonvulsant felbamate binding site in the N-methyl-D-aspartate receptor. J Med Chem 2008, 51:1534-1545.
13. Harty T.P., Rogawski M.A. Felbamate block of recombinant N-methyl-D-aspartate receptors: selectivity for the NR2B subunit. Epilepsy Res 2000, 39:47-55.